News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Evotec SE announces preliminary second quarter and first half 2026 results, updates full-year 2026 outlook. Key factors include revenue shift to 2027, strategic partnership delays, and base business momentum -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Evotec SE announces preliminary second quarter and first half 2026 results and updates full-year 2026 outlook, reflecting adjusted financial figures and revised guidance -
-
-
COMMUNIQUÉ DE PRESSE
Just – Evotec Biologics Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for Biologics
Evotec SE introduces J.TRAIN, a turnkey continuous manufacturing solution for biologics, enabling faster deployment and increased productivity. The model combines modular infrastructure, equipment, and technology for efficient capacity increase -